Status:
COMPLETED
A Pilot Study of Acupoint Injection for Primary Dysmenorrhea
Lead Sponsor:
University of California, San Francisco
Conditions:
Dysmenorrhea
Pain, Menstrual
Eligibility:
FEMALE
18-25 years
Phase:
NA
Brief Summary
Many women, particularly adolescent women, suffer from painful menstrual cramps, medically referred to as dysmenorrhea. Common treatments for menstrual cramps are non-steroidal anti-inflammatory drugs...
Eligibility Criteria
Inclusion
- Young women age 18-25
- Severe primary dysmenorrhea (defined as severe, recurrent painful periods for 6 months or more, that are not due to any other diagnosis, and that have not been relieved, or have been only partially relieved by any other treatment)
- Nulliparous
- English speaking
- No acute or chronic conditions diagnosed or suspected
- Not on hormonal contraceptives
- Regular menstrual cycles for at least 6 months
- Has a working phone or pager
Exclusion
- Use of hormonal contraceptives, or intra-uterine device
- Pregnancy
- Dysmenorrhea due to any other suspected or recognized causes
- History of abdominal surgery
- Participation in other concomitant therapy for acute or chronic pain
- Current treatment with anti-coagulant drugs for any reason
- Previous treatment with vitamin K acupoint injection
- Plans to be out of area during next 5 months
- Under age 18
- Known allergy to Vitamin K.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00995917
Start Date
October 1 2009
End Date
July 1 2011
Last Update
April 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Zion Outpatient Unit
San Francisco, California, United States, 94115